Pursuant to Regulation 30(6) of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, this is to inform you that the Company will be meeting Investors / Analysts on ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Pharma Industries has informed BSE about a virtual group meeting with investors and analysts scheduled for 3rd June 2025. The meeting will use the company's H2 FY25 Investor Presentation (March 2025), which is already publicly available on the company's website and BSE. The company noted that changes to the schedule may occur due to unforeseen circumstances. The intimation was signed by Nirav Shah, Company Secretary & Compliance Officer.
This is a routine disclosure with no new material information, as the presentation to be shared is already public. No immediate impact on stock price is expected from this announcement.